F
FDA
Guest
As part of the reauthorizations of the Prescription Drug User Fee Act (PDUFA VI) and the Biosimilar User Fee Act (BsUFA II), the Food and Drug Administration (FDA) committed to reporting quarterly updates on the progress made towards hiring goals for fiscal years (FY) 2018-2022.
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...